Resultados da pesquisa - Portal para modelos de dados médicos (portal MDM)

STEMI-Register Münster - STEMI-Register Münster Klinischer Verlauf

- 14/4/21 - 1 Formulário, 8 Grupos de itens, 83 Elementos de dados, 2 Idiomas

Grupos de itens: Demografisch, Patient history, Medication: pre hospital, Risk Factors, Admission examination, Investigations and Treatment, Outcome, Medication at discharge

STEMI-Register Münster

Kerala ACS Registry

- 14/4/21 - 1 Formulário, 8 Grupos de itens, 71 Elementos de dados, 1 Idioma

Grupos de itens: Demographics, Symptom, Physical examination, History, Investigations and Treatment, Medication, In Hospital Procedure, Outcome

Acute Coronary Syndrome Quality Improvement in Kerala (ACS QUIK) Cluster Randomized, Stepped Wedge Multi-center implementation of a Locally-Developed Quality Improvement Toolkit. (http://www.csikerala.org/acsregistry.php)

GRACE 2.0 ACS Risk Score - GRACE Score

- 10/4/21 - 1 Formulário, 1 Grupo de itens, 10 Elementos de dados, 1 Idioma

Grupo de itens: Score Items

GRACE (the Global Registry of Acute Coronary Events) is an international observational programme of outcomes for patients who were hospitalized with an ACS in the 10 years from 1999. GRACE includes nearly 250 hospitals in 30 countries, and enrolled a total of 102,341 patients. Participating physicians receive confidential quarterly reports showing their outcomes side by side with the aggregate outcomes of all participating hospitals. The GRACE Risk Score has been extensively validated prospectively and externally. (http://www.gracescore.org/WebSite/About.aspx)

Eligibility Myocardial Infarction NCT01218815

- 5/11/20 - 1 Formulário, 2 Grupos de itens, 18 Elementos de dados, 1 Idioma

Grupos de itens: Inclusion Criteria, Exclusion Criteria

Complete Infarct Related Artery Revascularization; ODM derived from: https://clinicaltrials.gov/show/NCT01218815

A Cross-Over Study of Alcohol Effect on the Pharmacokinetics of Carvedilol - 106904 - Logs and Repeats: 12-lead ECG Abnormalities

- 11/1/19 - 1 Formulário, 3 Grupos de itens, 16 Elementos de dados, 1 Idioma

Grupos de itens: Administrative data, 12-lead ECG Abnormalities, Record clinically significant abnormalities below. Check all that apply:

Study ID: 106904 Clinical Study ID: CRV106904 Study Title: A Randomized, Open-Label, Single-Dose, Four-Period Cross-Over Study to Determine the Effects of Alcohol on the Pharmacokinetics of Carvedilol CR Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: carvedilol Trade Name: Coreg CR,Coreg Study Indication: Hypertension

Eligibility Myocardial Infarction NCT00831116

- 8/1/19 - 1 Formulário, 2 Grupos de itens, 9 Elementos de dados, 1 Idioma

Grupos de itens: Inclusion Criteria, Exclusion Criteria

An Observational Study of Cholesterol in Coronary Arteries; ODM derived from: https://clinicaltrials.gov/show/NCT00831116

Pharmacokinetics of an oral contraceptive co-administered with Albiglutide in women - 107032 - Adjudication Events - Acute Myocardial Infraction/Hospitalized Angina or Chest Pain

- 7/1/19 - 1 Formulário, 12 Grupos de itens, 108 Elementos de dados, 1 Idioma

Grupos de itens: Administrative data, Acute Myocardial Infraction/Hospitalized Angina or Chest Pain, Clinical Presentation, Electrocardiographic Details, Cardiac Enzymes/Markers, CK-MB, Troponin I, Troponin T, Treatment Given for Acute MI/Hospitalized Angina/Chest Pain Event, Other Investigations Undertaken in View of this Event, Final Clinical Diagnosis, Narrative

Study ID: 107032 Clinical Study ID: GLP107032 Study Title: An open-label study to evaluate the pharmacokinetics of an oral contraceptive containing Norethindrone and Ethinyl Estradiol when co-administered with GSK716155 in healthy adult female subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01077505 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2

Estimation of Dose Proportionality of Darapladib - 107038 - Follow-Up: 12-lead ECG Abnormalities

- 13/11/18 - 1 Formulário, 8 Grupos de itens, 87 Elementos de dados, 1 Idioma

Grupos de itens: Administrative data, Record clinically significant abnormalities below., A. Rhythm, B. P-Wave Morphology, C. Conduction, D. Myocardial Infraction, E. Depolarisation/Repolarisation (QRS-T), F. Other

Study ID: 107038 Clinical Study ID: LPL107038 Study Title: Study to Estimate the Dose Proportionality of the Enteric-Coated Freebase Formulation of SB-480848 Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: Tyrisa ,US Study Indication: Atherosclerosis